Doi.org/10.1111/gbb.12373
Revision as of 10:00, 4 August 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566 ; Robert M J Deacon M J Hurley C M Rebolledo M Snape F J Altimiras L Farias M Pino R Biekofsky ; NULL; 02/17/2017; https://doi.org/10.1111/gbb.12373 == Reasons == Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.")
Target Article[edit | edit source]
Nrf2: a novel therapeutic target in fragile X syndrome is modulated by NNZ2566 ; Robert M J Deacon M J Hurley C M Rebolledo M Snape F J Altimiras L Farias M Pino R Biekofsky ; NULL; 02/17/2017; https://doi.org/10.1111/gbb.12373
Reasons[edit | edit source]
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.